PDB Short entry for 2RGP HEADER TRANSFERASE 04-OCT-07 2RGP TITLE STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 702-1016; COMPND 5 SYNONYM: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 STRAIN: HUMAN STRAINS UNDEFINED; SOURCE 5 GENE: EGFR, ERBB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: MODIFIED PDEST8 KEYWDS KINASE DOMAIN, ALTERNATIVE SPLICING, ANTI-ONCOGENE, ATP-BINDING, CELL KEYWDS 2 CYCLE, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, SECRETED, TRANSFERASE, KEYWDS 4 TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, UBL CONJUGATION EXPDTA X-RAY DIFFRACTION AUTHOR M.C.ABAD REVDAT 4 30-AUG-23 2RGP 1 REMARK REVDAT 3 25-OCT-17 2RGP 1 REMARK REVDAT 2 24-FEB-09 2RGP 1 VERSN REVDAT 1 26-AUG-08 2RGP 0 JRNL AUTH G.XU,M.C.ABAD,P.J.CONNOLLY,M.P.NEEPER,G.T.STRUBLE, JRNL AUTH 2 B.A.SPRINGER,S.L.EMANUEL,N.PANDEY,R.H.GRUNINGER,M.ADAMS, JRNL AUTH 3 S.MORENO-MAZZA,A.R.FUENTES-PESQUERA,S.A.MIDDLETON JRNL TITL 4-AMINO-6-ARYLAMINO-PYRIMIDINE-5-CARBALDEHYDE HYDRAZONES AS JRNL TITL 2 POTENT ERBB-2/EGFR DUAL KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 4615 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18653333 JRNL DOI 10.1016/J.BMCL.2008.07.020 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 22479 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2248 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2289 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.32700 REMARK 3 B22 (A**2) : 5.60600 REMARK 3 B33 (A**2) : 7.72100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.559 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.599 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.112 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.255 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : MSI_CNX_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : INH.PAR REMARK 3 PARAMETER FILE 3 : MSI_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : MSI_CNX_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RGP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000044837. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26482 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.20800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1XKK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M NA/K3PO4, 0.1M CAPS PH 9.0 AND 0.2M REMARK 280 LI2SO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.92500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.93000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.01500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.93000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.92500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.01500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 734 REMARK 465 GLY A 735 REMARK 465 GLU A 736 REMARK 465 LYS A 737 REMARK 465 GLU A 749 REMARK 465 ALA A 750 REMARK 465 THR A 751 REMARK 465 SER A 752 REMARK 465 PRO A 753 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 LYS A 875 REMARK 465 HIS A 988 REMARK 465 LEU A 989 REMARK 465 PRO A 990 REMARK 465 SER A 991 REMARK 465 PRO A 992 REMARK 465 THR A 993 REMARK 465 ASP A 994 REMARK 465 SER A 995 REMARK 465 GLU A 1004 REMARK 465 GLU A 1005 REMARK 465 ASP A 1006 REMARK 465 MET A 1007 REMARK 465 ASP A 1008 REMARK 465 ASP A 1009 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1015 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 715 -60.52 -97.49 REMARK 500 LEU A 782 74.60 -103.22 REMARK 500 THR A 783 -134.37 -93.32 REMARK 500 LYS A 806 -18.34 -49.77 REMARK 500 ARG A 836 -10.72 78.42 REMARK 500 ASP A 837 41.73 -148.25 REMARK 500 ARG A 986 75.20 -119.73 REMARK 500 PHE A 997 115.27 98.99 REMARK 500 TYR A 998 4.65 -50.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 81 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 82 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HYZ A 1 DBREF 2RGP A 702 1016 UNP P00533 EGFR_HUMAN 702 1016 SEQRES 1 A 315 ALA LEU LEU ARG ILE LEU LYS GLU THR GLU PHE LYS LYS SEQRES 2 A 315 ILE LYS VAL LEU GLY SER GLY ALA PHE GLY THR VAL TYR SEQRES 3 A 315 LYS GLY LEU TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE SEQRES 4 A 315 PRO VAL ALA ILE LYS GLU LEU ARG GLU ALA THR SER PRO SEQRES 5 A 315 LYS ALA ASN LYS GLU ILE LEU ASP GLU ALA TYR VAL MET SEQRES 6 A 315 ALA SER VAL ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY SEQRES 7 A 315 ILE CYS LEU THR SER THR VAL GLN LEU ILE THR GLN LEU SEQRES 8 A 315 MET PRO PHE GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS SEQRES 9 A 315 LYS ASP ASN ILE GLY SER GLN TYR LEU LEU ASN TRP CYS SEQRES 10 A 315 VAL GLN ILE ALA LYS GLY MET ASN TYR LEU GLU ASP ARG SEQRES 11 A 315 ARG LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU SEQRES 12 A 315 VAL LYS THR PRO GLN HIS VAL LYS ILE THR ASP PHE GLY SEQRES 13 A 315 LEU ALA LYS LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS SEQRES 14 A 315 ALA GLU GLY GLY LYS VAL PRO ILE LYS TRP MET ALA LEU SEQRES 15 A 315 GLU SER ILE LEU HIS ARG ILE TYR THR HIS GLN SER ASP SEQRES 16 A 315 VAL TRP SER TYR GLY VAL THR VAL TRP GLU LEU MET THR SEQRES 17 A 315 PHE GLY SER LYS PRO TYR ASP GLY ILE PRO ALA SER GLU SEQRES 18 A 315 ILE SER SER ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN SEQRES 19 A 315 PRO PRO ILE CYS THR ILE ASP VAL TYR MET ILE MET VAL SEQRES 20 A 315 LYS CYS TRP MET ILE ASP ALA ASP SER ARG PRO LYS PHE SEQRES 21 A 315 ARG GLU LEU ILE ILE GLU PHE SER LYS MET ALA ARG ASP SEQRES 22 A 315 PRO GLN ARG TYR LEU VAL ILE GLN GLY ASP GLU ARG MET SEQRES 23 A 315 HIS LEU PRO SER PRO THR ASP SER ASN PHE TYR ARG ALA SEQRES 24 A 315 LEU MET ASP GLU GLU ASP MET ASP ASP VAL VAL ASP ALA SEQRES 25 A 315 ASP GLU TYR HET PO4 A 81 5 HET PO4 A 82 5 HET HYZ A 1 33 HETNAM PO4 PHOSPHATE ION HETNAM HYZ N-[1-(3-FLUOROBENZYL)-1H-INDAZOL-5-YL]-5-[(PIPERIDIN-1- HETNAM 2 HYZ YLAMINO)METHYL]PYRIMIDINE-4,6-DIAMINE FORMUL 2 PO4 2(O4 P 3-) FORMUL 4 HYZ C24 H27 F N8 FORMUL 5 HOH *85(H2 O) HELIX 1 1 ALA A 755 SER A 768 1 14 HELIX 2 2 CYS A 797 HIS A 805 1 9 HELIX 3 3 GLY A 810 ARG A 831 1 22 HELIX 4 4 ALA A 839 ARG A 841 5 3 HELIX 5 5 GLY A 857 LEU A 862 1 6 HELIX 6 6 PRO A 877 MET A 881 5 5 HELIX 7 7 ALA A 882 ARG A 889 1 8 HELIX 8 8 THR A 892 THR A 909 1 18 HELIX 9 9 PRO A 919 SER A 921 5 3 HELIX 10 10 GLU A 922 LYS A 929 1 8 HELIX 11 11 THR A 940 TRP A 951 1 12 HELIX 12 12 ASP A 954 ARG A 958 5 5 HELIX 13 13 LYS A 960 ASP A 974 1 15 HELIX 14 14 ASP A 974 LEU A 979 1 6 HELIX 15 15 PHE A 997 ASP A 1003 1 7 SHEET 1 A 6 ARG A 705 ILE A 706 0 SHEET 2 A 6 LEU A 777 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 A 6 VAL A 786 GLN A 791 -1 O ILE A 789 N LEU A 778 SHEET 4 A 6 ILE A 740 LEU A 747 -1 N ALA A 743 O THR A 790 SHEET 5 A 6 GLY A 724 TRP A 731 -1 N TYR A 727 O ILE A 744 SHEET 6 A 6 PHE A 712 SER A 720 -1 N LYS A 716 O LYS A 728 SHEET 1 B 2 VAL A 843 THR A 847 0 SHEET 2 B 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 SITE 1 AC1 7 ARG A 803 LYS A 913 LYS A 970 ARG A 977 SITE 2 AC1 7 HOH A1074 HOH A1075 HOH A1093 SITE 1 AC2 5 ARG A 832 LEU A 833 ARG A 836 LYS A 860 SITE 2 AC2 5 HIS A 888 SITE 1 AC3 16 LEU A 718 GLY A 719 ALA A 743 LYS A 745 SITE 2 AC3 16 CYS A 775 ARG A 776 LEU A 777 LEU A 788 SITE 3 AC3 16 THR A 790 GLN A 791 MET A 793 ASP A 800 SITE 4 AC3 16 LEU A 844 THR A 854 ASP A 855 PHE A 856 CRYST1 45.850 68.030 103.860 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021810 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014699 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009628 0.00000